Search

everythinglearnresearchcommunity

for

Search:↓

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Male hormones can decrease the ability of immune cells to fight bacteria.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Androgen use may increase the risk of stroke, but more research is needed.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Finasteride's sexual side effects not caused by androgen deficiency or SRD5A inhibition.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Flutamide caused damage to male rat reproductive organs and may affect fertility.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Analog 23 is a promising compound for prostate cancer treatment.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen-modulating drugs do not significantly change the heat sensitivity of prostate cancer cells.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.